Mesenchymal stromal cells (MSCs) as a therapeutic agent of inflammatory disease and infectious COVID-19 virus: live or dead mesenchymal?
The COVID-19 infection is a worldwide disease that causes numerous immune-inflammatory
disorders, tissue damage, and lung dysfunction. COVID-19 vaccines, including those from …
disorders, tissue damage, and lung dysfunction. COVID-19 vaccines, including those from …
[HTML][HTML] The role of mesenchymal stromal cells in immune modulation of COVID-19: focus on cytokine storm
M Kavianpour, M Saleh, J Verdi - Stem Cell Research & Therapy, 2020 - Springer
The outbreak of coronavirus disease 2019 (COVID-19) pandemic is quickly spreading all
over the world. This virus, which is called SARS-CoV-2, has infected tens of thousands of …
over the world. This virus, which is called SARS-CoV-2, has infected tens of thousands of …
Mesenchymal stromal cells to fight SARS-CoV-2: Taking advantage of a pleiotropic therapy
The devastating global impact of the Severe Acute Respiratory Syndrome Coronavirus 2
(SARS-CoV-2) has prompted scientists to develop novel strategies to fight Coronavirus …
(SARS-CoV-2) has prompted scientists to develop novel strategies to fight Coronavirus …
[HTML][HTML] Mesenchymal stromal cells in viral infections: implications for COVID-19
JLM Rocha, WCF de Oliveira, NC Noronha… - Stem cell reviews and …, 2021 - Springer
Mesenchymal stromal cells (MSCs) constitute a heterogeneous population of stromal cells
with immunomodulatory and regenerative properties that support their therapeutic use …
with immunomodulatory and regenerative properties that support their therapeutic use …
[HTML][HTML] Mesenchymal stem cells (MSCs) as a potential therapeutic strategy in COVID-19 patients: literature research
A Coelho, RD Alvites, MV Branquinho… - Frontiers in cell and …, 2020 - frontiersin.org
In 2019, an outbreak of an unknown coronavirus–SARS-CoV-2–responsible for COVID-19
disease, was first reported in China, and evolved into a pandemic of huge dimensions and …
disease, was first reported in China, and evolved into a pandemic of huge dimensions and …
[HTML][HTML] Clinical efficacy and mechanism of mesenchymal stromal cells in treatment of COVID-19
K Lu, S Geng, S Tang, H Yang, W Xiong, F Xu… - Stem cell research & …, 2022 - Springer
Abstract Coronavirus disease 2019 (COVID-19) is a highly infectious epidemic disease that
has seriously affected human health worldwide. To date, however, there is still no definitive …
has seriously affected human health worldwide. To date, however, there is still no definitive …
Mesenchymal Stem Cells and COVID‐19: Cure, Prevention, and Vaccination
M Afarid, F Sanie-Jahromi - Stem cells international, 2021 - Wiley Online Library
COVID‐19 disease has been a global health problem since late 2019. There are many
concerns about the rapid spread of this disease, and yet, there is no approved treatment for …
concerns about the rapid spread of this disease, and yet, there is no approved treatment for …
[HTML][HTML] The use of mesenchymal stromal cells in the treatment of coronavirus disease 2019
MA Canham, JDM Campbell, JC Mountford - Journal of Translational …, 2020 - Springer
More than seven months into the coronavirus disease-19 (COVID-19) pandemic, infection
from the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has led to over …
from the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has led to over …
[HTML][HTML] Mesenchymal stem cell-based treatments for COVID-19: status and future perspectives for clinical applications
L Chen, J Qu, FS Kalyani, Q Zhang, L Fan… - Cellular and Molecular …, 2022 - Springer
As a result of cross-species transmission in December 2019, the coronavirus disease 2019
(COVID-19) became a serious endangerment to human health and the causal agent of a …
(COVID-19) became a serious endangerment to human health and the causal agent of a …
[HTML][HTML] The coronavirus pandemic (SARS-CoV-2): New problems demand new solutions, the alternative of mesenchymal (stem) stromal cells
N Eiro, JR Cabrera, M Fraile, L Costa… - Frontiers in Cell and …, 2020 - frontiersin.org
Mesenchymal (stem) stromal cells (MSC) can be a therapeutic alternative for COVID-19
considering their anti-inflammatory, regenerative, angiogenic, and even antimicrobial …
considering their anti-inflammatory, regenerative, angiogenic, and even antimicrobial …